Literature DB >> 33592275

Inhibition of ERK1/2 phosphorylation attenuates spinal cord injury induced astrocyte activation and inflammation through negatively regulating aquaporin-4 in rats.

Jian Li1, Zhiqiang Jia2, Qiangqiang Zhang1, Junyu Dai1, Jundong Kong1, Zhongkai Fan3, Gang Li4.   

Abstract

The extracellular signal-regulated kinase (ERK) pathway has been reported to play a pivotal role in mediating spinal cord injury (SCI) progression. The present study aimed to investigate the effects of phosphorylated ERK1/2 (p-ERK1/2) inhibition on SCI-induced astrocyte activation and inflammation and its possible mechanism in rats. Here, female Sprague-Dawley rats were randomly assigned to four groups: (1) Sham group, (2) SCI group, (3) TGN-020 group (aquaporin-4, AQP4, blocking agent), (4) PD98059 group (ERK blocking agent). A well SCI model was established by compressing the thoracic vertebra 10 level (weight 35 g, time 5 min) in rats. Western blotting and immunofluorescence staining were used to measure the expression of associated proteins after SCI. HE staining and Nissl staining were performed to detect the morphological changes of spinal cords and the number of surviving neurons following SCI, respectively. The Basso-Beattie-Bresnahan open-field rating scale was used to evaluate functional locomotor recovery following SCI in rats. Our results demonstrated that SCI significantly induced the upregulation of aquaporin-4, p-ERK1/2, glial fibrillary acidic protein, proliferating cell nuclear antigen, and proinflammatory cytokines (tumor necrosis factor-α, interleukin-6 and interleukin-1β). However, treatment with TGN-020 or PD98059 could effectively inhibit astrocyte proliferation and proinflammatory cytokine release, preserve the number of surviving ventral horn neurons, and subsequently improve the locomotor function of rats after SCI. Interestingly, the SCI-induced elevation of AQP4 expression was downregulated by p-ERK1/2 inhibition, suggesting that blocking ERK1/2 phosphorylation could attenuate astrocyte activation and inflammatory processes through negative regulation of AQP4. Therefore, p-ERK1/2 blockade may be employed as a therapeutic target for SCI.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aquaporin-4; Astrocyte activation; Inflammation; Phosphorylated ERK1/2; Spinal cord injury

Mesh:

Substances:

Year:  2021        PMID: 33592275     DOI: 10.1016/j.brainresbull.2021.02.014

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  S1PR3, as a Core Protein Related to Ischemic Stroke, is Involved in the Regulation of Blood-Brain Barrier Damage.

Authors:  Xuehui Fan; Hongping Chen; Chen Xu; Yingju Wang; Pengqi Yin; Meng Li; Zhanbin Tang; Fangchao Jiang; Wan Wei; Jihe Song; Guozhong Li; Di Zhong
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

Review 2.  Reactive Astrocytes in Central Nervous System Injury: Subgroup and Potential Therapy.

Authors:  GuiLian Yu; Ying Zhang; Bin Ning
Journal:  Front Cell Neurosci       Date:  2021-12-23       Impact factor: 5.505

Review 3.  Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration.

Authors:  Daniel J Hellenbrand; Charles M Quinn; Zachariah J Piper; Carolyn N Morehouse; Jordyn A Fixel; Amgad S Hanna
Journal:  J Neuroinflammation       Date:  2021-12-07       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.